Molecular Dynamics-Assisted Discovery of Novel Phosphodiesterase-5 Inhibitors Targeting a Unique Allosteric Pocket
Phosphodiesterase-5 (PDE5) is a potent therapeutic target for the treatment of male erectile dysfunction and pulmonary arterial hypertension with several drugs available on the market. However, most of the reported PDE5 inhibitors lack specificity over PDE6, a holoenzyme in eleven PDE families, whic...
Saved in:
| Main Authors: | Weihao Luo, Runduo Liu, Xinlin Cai, Qian Zhou, Chen Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/30/3/588 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reduced Airway Hyperresponsiveness by Phosphodiesterase 3 and 4 Inhibitors
in Guinea-Pigs
by: Nöella Germain, et al.
Published: (1999-01-01) -
Phosphodiesterase-5 inhibitors: Raynaud's and beyond
by: Sanat Phatak, et al.
Published: (2017-01-01) -
Discovery of highly potent phosphodiesterase-1 inhibitors by a combined-structure free energy perturbation approach
by: Zhe Li, et al.
Published: (2024-12-01) -
A review of phosphodiesterase type 5 inhibitors
by: N. Schellack, et al.
Published: (2014-05-01) -
PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE
by: M. N. Mamedov, et al.
Published: (2016-01-01)